Activation of NMDA receptors in brain endothelial cells increases transcellular permeability

Fluids Barriers CNS. 2022 Sep 6;19(1):70. doi: 10.1186/s12987-022-00364-6.

Abstract

Neurovascular coupling is a precise mechanism that induces increased blood flow to activated brain regions, thereby providing oxygen and glucose. In this study, we hypothesized that N-methyl-D-aspartate (NMDA) receptor signaling, the most well characterized neurotransmitter signaling system which regulates delivery of essential molecules through the blood-brain barrier (BBB). Upon application of NMDA in both in vitro and in vivo models, increased delivery of bioactive molecules that was mediated through modulation of molecules involved in molecular delivery, including clathrin and caveolin were observed. Also, NMDA activation induced structural changes in the BBB and increased transcellular permeability that showed regional heterogeneity in its responses. Moreover, NMDA receptor activation increased endosomal trafficking and facilitated inactivation of lysosomal pathways and consequently increased molecular delivery mediated by activation of calmodulin-dependent protein kinase II (CaMKII) and RhoA/protein kinase C (PKC). Subsequent in vivo experiments using mice specifically lacking NMDA receptor subunit 1 in endothelial cells showed decreased neuronal density in the brain cortex, suggesting that a deficiency in NMDA receptor signaling in brain endothelial cells induces neuronal losses. Together, these results highlight the importance of NMDA-receptor-mediated signaling in the regulation of BBB permeability that surprisingly also affected CD31 staining.

MeSH terms

  • Animals
  • Brain / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Endothelial Cells / metabolism
  • Mice
  • N-Methylaspartate* / pharmacology
  • Permeability
  • Receptors, N-Methyl-D-Aspartate* / metabolism

Substances

  • Receptors, N-Methyl-D-Aspartate
  • N-Methylaspartate
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2